Literature DB >> 15280839

Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.

Christie L Carroll1, Steven R Feldman, Fabian T Camacho, Janeen C Manuel, Rajesh Balkrishnan.   

Abstract

INTRODUCTION: Medication nonadherence is common throughout medicine, and research into this area is increasing; however, knowledge about topical medication adherence is limited.
METHODS: A total of 30 patients were enrolled in a clinical trial for psoriasis and followed up for 8 weeks using 3 methods of adherence monitoring: electronic monitoring caps; medication logs; and medication usage by weight.
RESULTS: Adherence rates calculated from the medication logs and medication weights were consistently higher than those of the electronic monitors (P <.05). Electronically measured adherence rates declined from 84.6% to 51% during the 8-week study (P <.0001). Female sex and increasing age by 1 year predicted improved adherence of 5% and 0.8%, respectively (P <.0001). The number of treatment gaps increased from the first half to the last half of the study, and weekend days were overrepresented in treatment gaps.
CONCLUSION: Medication logs and weights do not ensure medication adherence to topical therapy. Electronic monitoring allows a more precise method of adherence measurement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280839     DOI: 10.1016/j.jaad.2004.01.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  20 in total

1.  Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits.

Authors:  Chuck W Lynde; Anneke Andriessen; Benjamin Barankin; Gillian De Gannes; Wayne Gulliver; Richard Haber; Catherine McCuaig; Poonam Rajan; Sandra P Skotnicki; Richard Thomas; Jack Toole; Ron Vender
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

Review 2.  [Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs].

Authors:  J Schmitt; M Meurer
Journal:  Hautarzt       Date:  2006-08       Impact factor: 0.751

Review 3.  Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.

Authors:  Sam G Raney; Thomas J Franz; Paul A Lehman; Robert Lionberger; Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2015-11       Impact factor: 6.447

4.  Increasing patient adherence in antifungal infection treatment: once-daily dosing of sertaconazole.

Authors:  Jeffrey M Weinberg
Journal:  J Clin Aesthet Dermatol       Date:  2009-02

Review 5.  Adolescent Scalp Psoriasis: Update on Topical Combination Therapy.

Authors:  Emily Osier; Barbara Gomez; Lawrence F Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2015-07

6.  Is antiretroviral therapy adherence substantially worse on weekends than weekdays?

Authors:  Marcus Bachhuber; Warren B Bilker; Hao Wang; Jennifer Chapman; Robert Gross
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

7.  A study of medication-taking and unobtrusive, intelligent reminding.

Authors:  Tamara L Hayes; Kofi Cobbinah; Terry Dishongh; Jeffrey A Kaye; Janna Kimel; Michael Labhard; Todd Leen; Jay Lundell; Umut Ozertem; Misha Pavel; Matthai Philipose; Kevin Rhodes; Sengul Vurgun
Journal:  Telemed J E Health       Date:  2009-10       Impact factor: 3.536

8.  Retinoid plus antimicrobial combination treatments for acne.

Authors:  Ashley N Feneran; William S Kaufman; Tushar S Dabade; Steven R Feldman
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-07-01

9.  Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized.

Authors:  Michael E Farhangian; William W Huang; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2015-04-22

10.  Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris.

Authors:  Efstratios Vakirlis; Athanasios Kastanis; Demetrios Ioannides
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.